The average price target for Telomir Pharmaceuticals, Inc. is 8.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 492.59% Increase from the current price of $1.35.